GlobalFoundries' Tim Stone leaves company just 2 months after being appointed CFO
Shares of GlobalFoundries Inc. (GFS) rallied 1.0% in premarket trading Tuesday, after the semiconductor foundry company said Tim Stone will not assume his duties as chief financial officer, and will leave the company effective today. The announcement comes just two months after the company said it appointed Stone as the new CFO, taking over for Dave Reeder who will leave the company after transitioning the role to Stone "over the coming months." On Tuesday, the company said Reeder will stay with the company as CFO through the end of the year, as the company searches for a new CFO. Separately, the company affirmed its second-quarter financial guidance provided on May 9, including adjusted earnings per share of 46 cents to 54 cents and revenue of $1.81 billion to $1.85 billion. The FactSet consensus is for EPS of 50 cents and revenue of $1.83 billion. The stock has climbed 19.4% year to date through Monday, while the S&P 500 has advanced 14.9%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-11-23 0825ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?